After 6 years with Xolair; a 3-year withdrawal follow-up von Nopp, A, Johansson, S.G.O, Adédoyin, J, Ankerst, J, Palmqvist, M, Öman, H

Volltext

Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents von Harboe, T, Johansson, S.G.O, Florvaag, E, Öman, H

Volltext

CD-sens: a biological measure of immunological changes stimulated by ASIT von Nopp, A, Cardell, L.O, Johansson, S.G.O, Öman, H

Volltext

CD‐sens and clinical changes during withdrawal of Xolair after 6 years of treatment von Nopp, A., Johansson, S. G. O., Ankerst, J., Palmqvist, M., Öman, H.

Volltext

Pholcodine caused anaphylaxis in Sweden 30 years ago von Johansson, S.G.O, Öman, H, Nopp, A, Florvaag, E

Volltext

Basophil allergen threshold sensitivity: a useful approach to anti‐IgE treatment efficacy evaluation von Nopp, A., Johansson, S. G. O., Ankerst, J., Bylin, G., Cardell, L. O., Grönneberg, R., Irander, K., Palmqvist, M., Öman, H.

Volltext

Anaphylaxis to Patent Blue V. II. A unique IgE-mediated reaction von Johansson, S.G.O, Nopp, A, Öman, H, Stahl-Skov, P, Hunting, A.S, Guttormsen, A.B

Volltext

No consumption of IgE antibody in serum during allergic drug anaphylaxis von Guttormsen, A.B, Johansson, S.G.O, Öman, H, Wilhelmsen, V, Nopp, A

Volltext

Xolair Is Effective in Allergics with a Low Serum IgE Level von Ankerst, J., Nopp, A., Johansson, S.G.O., Adédoyin, J., Öman, H.

Volltext

National pholcodine consumption and prevalence of IgE‐sensitization: a multicentre study von Johansson, S. G. O., Florvaag, E., Öman, H., Poulsen, L. K., Mertes, P. M., Harper, N. J. N., Garvey, L. H., Gerth van Wijk, R., Metso, T., Irgens, A., Dybendal, T., Halsey, J., Seneviratne, S. L., Guttormsen, A. B.

Volltext

size of the disease relevant IgE antibody fraction in relation to 'total-IgE' predicts the efficacy of anti-IgE (Xolair®) treatment von Johansson, S.G.O, Nopp, A, Öman, H, Ankerst, J, Cardell, L.O, Grönneberg, R, Matsols, H, Rudblad, S, Strand, V, Stålenheim, G

Volltext

Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively von Florvaag, E., Johansson, S. G. O., Öman, H., Venemalm, L., Degerbeck, F., Dybendal, T., Lundberg, M.

Volltext

Simultaneous exposure of several allergens has an additive effect on multisensitized basophils von Nopp, A., Johansson, S. G. O., Lundberg, M., Öman, H.

Volltext

Passive IgE‐sensitization by blood transfusion von Johansson, S. G. O., Nopp, A., Hage, M., Olofsson, N., Lundahl, J., Wehlin, L., Söderström, L., Stiller, V., Öman, H.

Volltext

Pholcodine stimulates a dramatic increase of IgE in IgE‐sensitized individuals. A pilot study von Florvaag, E., Johansson, S. G. O., Öman, H., Harboe, T., Nopp, A.

Volltext

The importance of IgE antibody levels in anti‐IgE treatment von Johansson, S. G. O., Öman, H., Nopp, A., Pettersson, S.

Volltext

High prevalence of IgE antibodies among blood donors in Sweden and Norway von Johansson, S. G. O., Nopp, A., Florvaag, E., Lundahl, J., Söderström, T., Guttormsen, A. B., Hervig, T., Lundberg, M., Öman, H., Hage, M.

Volltext

Anaphylaxis to atracurium - a non-QAI-dependent reaction? von Johansson, S.G.O., Öman, H., Degerbeck, F., Tunelli, J., Florvaag, E., Nopp, A.

Volltext

Cat IgA, representative of new carbohydrate cross-reactive allergens von Adédoyin, Justus, MSc, Grönlund, Hans, PhD, Öman, Hans, PhD, Johansson, S.G.O., MD, PhD, van Hage, Marianne, MD, PhD

Volltext

The International Network for Evaluating Outcomes (iNeo) of neonates: evolution, progress and opportunities von Shah, Prakesh S, Lui, Kei, Reichman, Brian, Norman, Mikael, Kusuda, Satoshi, Lehtonen, Liisa, Adams, Mark, Vento, Maximo, Darlow, Brian A, Modi, Neena, Rusconi, Franca, Håkansson, Stellan, San Feliciano, Laura, Helenius, Kjell K, Bassler, Dirk, Hirano, Shinya, Lee, Shoo K

Volltext